Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles: Focus on Anti-Centromere and Anti-RNA Polymerase III Antibodies
Related Posts
Cirulis MM, Auger WR, Benza RL, Channick RN, Chin K, Davis RD, Elliott CG, He F, Jain S, LaCroix AZ, Madani MM, McLaughlin V, Tapson[...]
Tincopa M, Bridi L, Vodkin I, Yilma M, Zhou K, Kwong A, Singh J, Mehta N, Kuo A, Hirose R, Wisel SA, Steggerda JA, Freise[...]
Conn BM, Durazo-Arvizu R, Wong CF, West AE, Chen D, Chan YM, Ehrensaft D, Garofalo R, Hidalgo MA, Rosenthal SM, Olson-Kennedy J. Gender Minority Stress[...]